Santhera Pharmaceuticals Holding AG (SANN) - Total Assets

Latest as of December 2025: CHF148.09 Million CHF ≈ $187.22 Million USD

Based on the latest financial reports, Santhera Pharmaceuticals Holding AG (SANN) holds total assets worth CHF148.09 Million CHF (≈ $187.22 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Santhera Pharmaceuticals Holding AG - Total Assets Trend (2006–2025)

This chart illustrates how Santhera Pharmaceuticals Holding AG's total assets have evolved over time, based on quarterly financial data. Also see Santhera Pharmaceuticals Holding AG market cap and net worth for the company's overall valuation and market capitalisation.

Santhera Pharmaceuticals Holding AG - Asset Composition Analysis

Current Asset Composition (December 2025)

Santhera Pharmaceuticals Holding AG's total assets of CHF148.09 Million consist of 54.2% current assets and 45.8% non-current assets. Review Santhera Pharmaceuticals Holding AG (SANN) total liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (CHF)	% of Total Assets
Cash & Equivalents	CHF0.00	15.2%
Accounts Receivable	CHF26.04 Million	17.6%
Inventory	CHF24.87 Million	16.8%
Property, Plant & Equipment	CHF0.00	0.0%
Intangible Assets	CHF63.94 Million	43.2%
Goodwill	CHF0.00	0.0%

Asset Composition Trend (2006–2025)

This chart illustrates how Santhera Pharmaceuticals Holding AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See SANN share price today for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Santhera Pharmaceuticals Holding AG's current assets represent 54.2% of total assets in 2025, a decrease from 78.9% in 2006.
Cash Position: Cash and equivalents constituted 15.2% of total assets in 2025, down from 77.4% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 43.0% of total assets, an increase from 19.0% in 2006.
Asset Diversification: The largest asset category is intangible assets at 43.2% of total assets.

Santhera Pharmaceuticals Holding AG Competitors by Total Assets

Key competitors of Santhera Pharmaceuticals Holding AG based on total assets are shown below.

Company	Country	Total Assets
Tubize-Fin BR:TUB	Belgium	€1.99 Billion
Dianthus Therapeutics Inc. NASDAQ:DNTH	USA	$1.21 Billion
Tango Therapeutics Inc NASDAQ:TNGX	USA	$1.07 Billion
Damora Therapeutics, Inc. NASDAQ:DMRA	USA	$543.64 Million
Apnimed, Inc. Common Stock NASDAQ:APMD	USA	$342.63 Million
Wecome Pharmaceutical Co Ltd SHE:300878	China	CN¥1.49 Billion
Tectonic Therapeutic, Inc. NASDAQ:TECX	USA	$246.58 Million
Relmada Therapeutics Inc NASDAQ:RLMD	USA	$235.36 Million

Santhera Pharmaceuticals Holding AG - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.29	1.64	0.61
Quick Ratio	0.89	1.26	0.59
Cash Ratio	0.00	0.00	0.00
Working Capital	CHF18.07 Million	CHF29.67 Million	CHF-11.35 Million

Santhera Pharmaceuticals Holding AG - Advanced Valuation Insights

This section examines the relationship between Santhera Pharmaceuticals Holding AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	6.48
Latest Market Cap to Assets Ratio	1.64
Asset Growth Rate (YoY)	-2.9%
Total Assets	CHF148.09 Million
Market Capitalization	$243.45 Million USD

Valuation Analysis

Above Book Valuation: The market values Santhera Pharmaceuticals Holding AG's assets above their book value (1.64x), reflecting positive investor sentiment about the company's future prospects.

Slight Asset Contraction: Santhera Pharmaceuticals Holding AG's assets decreased by 2.9% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Santhera Pharmaceuticals Holding AG (2006–2025)

The table below shows the annual total assets of Santhera Pharmaceuticals Holding AG from 2006 to 2025.

Year	Total Assets	Change
2025-12-31	CHF148.09 Million ≈ $187.22 Million	-2.89%
2024-12-31	CHF152.49 Million ≈ $192.79 Million	+39.09%
2023-12-31	CHF109.63 Million ≈ $138.60 Million	+72.03%
2022-12-31	CHF63.73 Million ≈ $80.57 Million	-30.06%
2021-12-31	CHF91.12 Million ≈ $115.20 Million	+2.74%
2020-12-31	CHF88.69 Million ≈ $112.12 Million	-22.92%
2019-12-31	CHF115.05 Million ≈ $145.46 Million	+4.31%
2018-12-31	CHF110.29 Million ≈ $139.44 Million	+0.47%
2017-12-31	CHF109.78 Million ≈ $138.79 Million	+20.91%
2016-12-31	CHF90.79 Million ≈ $114.79 Million	-22.50%
2015-12-31	CHF117.15 Million ≈ $148.11 Million	+410.58%
2014-12-31	CHF22.95 Million ≈ $29.01 Million	+135.67%
2013-12-31	CHF9.74 Million ≈ $12.31 Million	-46.75%
2012-12-31	CHF18.29 Million ≈ $23.12 Million	-64.86%
2011-12-31	CHF52.03 Million ≈ $65.79 Million	-33.94%
2010-12-31	CHF78.77 Million ≈ $99.58 Million	-16.83%
2009-12-31	CHF94.70 Million ≈ $119.73 Million	-16.15%
2008-12-31	CHF112.95 Million ≈ $142.80 Million	-21.66%
2007-12-31	CHF144.18 Million ≈ $182.28 Million	-11.22%
2006-12-31	CHF162.39 Million ≈ $205.31 Million	--

About Santhera Pharmaceuticals Holding AG

SW:SANN Switzerland Biotechnology

Market Cap

$286.57 Million

CHF226.67 Million CHF

Market Cap Rank

#15866 Global

#170 in Switzerland

Share Price

CHF15.94

Change (1 day)

+1.27%

52-Week Range

CHF9.58 - CHF18.54

All Time High

CHF1070.00